Diagnosing rare diseases, such as choroid neoplasias, remains a critical challenge. Here, the authors develop a multimodal concept-based interpretable model (MMCBM) to distinguish uveal melanoma ...

in early-stage choroidal melanoma. Bel-sar is from a novel class of virus-like drug conjugate therapies that Boston, Massachusetts-based Aura is developing for various oncology indications.

Choroidal neovascularization (CNV) is one of the most important vision-threatening complications secondary to pathological myopia (PM). In the last 20 years, there have been rapid advances in the ...

Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma—a highly aggressive and hard-to-treat form of skin cancer. The study ...

Diagnosing rare diseases, such as choroid neoplasias, remains a critical challenge. Here, the authors develop a multimodal concept-based interpretable model (MMCBM) to distinguish uveal melanoma ...

mRNA specialist BioNTech has chalked up an important win in its cancer pipeline, showing efficacy with its BNT111 vaccine candidate in a phase 2 trial in advanced melanoma. The study is looking at ...

生长特性：贴壁生长;形态特性：详见产品说明书;相关产品有：Ocular Choroidal Melanoma-1细胞、N87细胞、210RCY3-Ag1.2.3细胞 GM00637H Cells;背景说明：详见相关文献介绍;传代方法：1：2-1：3传代；每周换液2-3次。;生长特性：贴壁或悬浮，详见产品说明书部分 ...

High-sensitivity C-reactive protein and risk of retinal artery occlusion and ischaemic stroke: a cross-cohort study ...

Melanoma is a type of skin cancer. When it spreads to other places in your body, it's called metastatic, or advanced. If you have fair skin or you’ve spent lots of time in the sun, it’s a ...

PENNSYLVANIA, USA — Melanoma is a type of skin cancer primarily caused by sun exposure. "Sun exposure causes damage to the cells in your skin and causes abnormal growth of melanocytes ...

Melanoma has a high potential to spread to other parts of the body GETTY In a recent TikTok clip, the double board-certified dermatologist said: “It’s not a pimple, and it’s also not sebaceous ...